XML 23 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net income $ 12,805 $ 8,090 $ 6,628
Adjustments to reconcile net income to net cash provided by operating activities:      
Net premium amortization (discount accretion) 1,406 4,034 5,295
Depreciation and amortization expense 3,642 3,265 2,951
Provision for loan losses 800 1,000 250
Share-based compensation 1,493 1,386 958
Gain on sales of loans originated for sale (2,144) (2,447) (2,998)
Mortgage loans originated for sale (90,305) (104,512) (108,632)
Proceeds from sales of loans originated for sale 94,727 103,131 114,139
Gain on sale of portfolio loans (291) (32) 0
Net gain on disposal of OREO (108) (18) (182)
Writedown of OREO 24 4 183
Net (gain) loss on disposal of premises and equipment 12 (18) 147
Deferred income taxes 543 3,078 (232)
Investment securities gains (1,006) (1,190) (1,420)
Income from life insurance (1,463) (1,109) (1,099)
Increase in accrued interest receivable (879) (376) (827)
Increase in accrued interest payable and other liabilities 2,696 2,012 561
Other, net 535 52 (135)
Net cash provided by operating activities 22,487 16,350 15,587
Cash flows from investing activities      
Proceeds from sale of AFS securities 156,364 162,320 64,742
Maturities, repayments and calls of AFS securities 18,373 28,768 30,192
Purchases of AFS securities (226,014) (203,719) (108,448)
Net cash and cash equivalents received from acquisition 12,407 0 0
Net (purchases) redemptions of restricted investments in bank stocks (592) (2,027) 750
Net increase in loans (99,828) (130,791) (108,509)
Proceeds from sales of portfolio loans 3,589 2,195 5,100
Purchases of bank premises and equipment (4,791) (2,653) (13,369)
Proceeds from disposal of OREO 1,413 541 1,090
Purchases of bank owned life insurance (900) (600) 0
Death benefit proceeds from life insurance contracts 576 0 0
Other 7 74 (439)
Net cash used in investing activities (139,396) (145,892) (128,891)
Cash flows from financing activities      
Net increase in deposits 178,798 67,063 120,285
Net increase (decrease) in borrowings with original maturities less than 90 days (14,507) (34,288) 18,708
Proceeds from other short-term borrowings 25,000 70,000 0
Payments on other short-term borrowings (40,000) (30,000) (20,000)
Proceeds from long-term debt 0 80,000 0
Payments on long-term debt (365) (20,348) (332)
Proceeds from subordinated notes, net of issuance costs 31,857 0 0
Dividends paid (4,375) (3,488) (2,898)
Acquisition of treasury stock 0 0 (631)
Treasury shares repurchased for employee taxes associated with restricted stock vesting (651) 0 0
Proceeds from issuance of stock for option exercises and employee stock purchase plan 160 137 105
Net cash provided by financing activities 175,917 129,076 115,237
Net increase (decrease) in cash and cash equivalents 59,008 (466) 1,933
Cash and cash equivalents at beginning of year 29,807 30,273 28,340
Cash and cash equivalents at end of year 88,815 29,807 30,273
Supplemental disclosure of cash flow information [Abstract]      
Interest 12,930 7,586 5,346
Income taxes 60 1,638 1,300
Supplemental schedule of noncash investing and financing Activities [Abstract]      
Other real estate acquired in settlement of loans 539 1,007 688
Premises And Equipment Transferred To Held For Sale $ 1,003 $ 0 $ 0